SCHEMBL1992064

SCHEMBL1992064

Cc1ccc(OC(C(=O)O)C(C)(C)C)c(-c2ccc(S(=O)(=O)c3ccc(F)cc3)c(F)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 3/20 0.39
ABCB11 O95342 1/20 0.38
MMP1 P03956 2/20 0.35
MMP2 P08253 2/20 0.35
MMP3 P08254 2/20 0.35
MMP9 P14780 2/20 0.35
MMP13 P45452 2/20 0.35
MMP7 P09237 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MMP12 P39900 1/20 0.34
MMP14 P50281 1/20 0.34
HSD11B1 P28845 1/20 0.34
CNR1 P21554 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
NAMPT P43490 1/20 0.34
CNR2 P34972 1/20 0.33
ABCC9 O60706 1/20 0.33
ABCC8 Q09428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990982 0.93 ABCC9 (0.40) PTGDR2ABCB11MMP1MMP2MMP3
SCHEMBL14828506 0.89 PTGDR2 (0.43) PTGDR2ABCB11HSD11B1CNR1KCNQ3
SCHEMBL1992682 0.84 PTGDR2 (0.37) PTGDR2MEN1KMT2AHSD11B1KEAP1
SCHEMBL2908208 0.81 PTGS2 (0.47) MEN1KMT2ANR1I2PTGS2
SCHEMBL1993889 0.81 PTGDR2 (0.54) PTGDR2MMP1MMP2MMP3MMP9
SCHEMBL2347649 0.79 PTGDR2 (0.40) PTGDR2ABCB11CTSA
SCHEMBL1988641 0.78 ABCB11 (0.50) PTGDR2ABCB11MMP1MMP2MMP3
SCHEMBL1989421 0.76 NPC1 (0.44) PTGDR2MEN1KMT2AHSD11B1NAMPT
SCHEMBL1992062 0.76 ABCB11 (0.49) PTGDR2ABCB11MMP1MMP2MMP3
SCHEMBL1995866 0.74 ABCB11 (0.46) PTGDR2ABCB11MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415394-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (GB) 2013-04-09 US disclosed
US-8008350-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2011-08-30 US disclosed
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD PTGDR2 568/4885ABCB11 193/4885MMP1 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.